Literature DB >> 28238836

Modulation of hepatic stellate cells and reversibility of hepatic fibrosis.

Yu Huang1, Xin Deng2, Jian Liang3.   

Abstract

Hepatic fibrosis (HF) is the pathological component of a variety of chronic liver diseases. Hepatic stellate cells (HSC) are the main collagen-producing cells in the liver and their activation promotes HF. If HSC activation and proliferation can be inhibited, HF occurrence and development can theoretically be reduced and even reversed. Over the past ten years, a number of studies have addressed this process, and here we present a review of HSC modulation and HF reversal.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatic fibrosis; Hepatic stellate cells; Mechanism; Modulation; Reversibility

Mesh:

Substances:

Year:  2017        PMID: 28238836     DOI: 10.1016/j.yexcr.2017.02.038

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  34 in total

1.  [Characteristics of peripheral rheograms following thermal provocation in normal and pathologic pregnancy].

Authors:  A Feiks; C Nowotny; W Gruber
Journal:  Geburtshilfe Frauenheilkd       Date:  1988-09       Impact factor: 2.915

Review 2.  Hepatic Stellate Cell: A Double-Edged Sword in the Liver.

Authors:  Nianan Luo; Jiangbin Li; Yu Wei; Jianguo Lu; Rui Dong
Journal:  Physiol Res       Date:  2021-10-30       Impact factor: 1.881

Review 3.  Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases.

Authors:  Minyang Fu; Dandan Peng; Tianxia Lan; Yuquan Wei; Xiawei Wei
Journal:  Acta Pharm Sin B       Date:  2022-01-19       Impact factor: 14.903

4.  MicroRNA-15a inhibits hepatic stellate cell activation and proliferation via targeting SRY-box transcription factor 9.

Authors:  Maoying Fu; Weihua Yin; Wei Zhang; Yanfang Zhu; Huihui Ni; Li Gong
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

5.  Anti-liver fibrosis effects of the total flavonoids of litchi semen on CCl4-induced liver fibrosis in rats associated with the upregulation of retinol metabolism.

Authors:  Jiongyi Yan; Yinyi Feng; Xuewan Fang; Xiaojuan Cui; Xing Xia; Fang Li; Weisheng Luo; Jianqin Liang; Jianfang Feng; Kai Yu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

6.  Cellular and molecular effects of silymarin on the transdifferentiation processes of LX-2 cells and its connection with lipid metabolism.

Authors:  Caio Mateus Silva; Gustavo Duarte Ferrari; Luciane Carla Alberici; Osmar Malaspina; Karen C M Moraes
Journal:  Mol Cell Biochem       Date:  2020-03-17       Impact factor: 3.396

7.  The Bioactive Extract of Pinnigorgia sp. Induces Apoptosis of Hepatic Stellate Cells via ROS-ERK/JNK-Caspase-3 Signaling.

Authors:  Liang-Mou Kuo; Po-Jen Chen; Ping-Jyun Sung; Yu-Chia Chang; Chun-Ting Ho; Yi-Hsiu Wu; Tsong-Long Hwang
Journal:  Mar Drugs       Date:  2018-01-09       Impact factor: 5.118

8.  Dioscin Inhibits HSC-T6 Cell Migration via Adjusting SDC-4 Expression: Insights from iTRAQ-Based Quantitative Proteomics.

Authors:  Lianhong Yin; Yan Qi; Youwei Xu; Lina Xu; Xu Han; Xufeng Tao; Shasha Song; Jinyong Peng
Journal:  Front Pharmacol       Date:  2017-09-20       Impact factor: 5.810

9.  Tumor-specific hepatic stellate cells (tHSCs) induces DIgR2 expression in dendritic cells to inhibit T cells.

Authors:  Yun-Hong Xia; Zhen Lu; Min Zhao; Wen-Ting Dai; Lu Ding; Li-Xia Hu; Guo-Lin Jiang
Journal:  Oncotarget       Date:  2017-07-05

Review 10.  Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy.

Authors:  Bárbara González-Fernández; Diana I Sánchez; Javier González-Gallego; María J Tuñón
Journal:  Front Pharmacol       Date:  2017-08-25       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.